Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Docetaxel Consolidation Therapy Following Cisplatin, Vinorelbine, and Concurrent Thoracic Radiotherapy in Patients with Unresectable Stage III Non-small Cell Lung Cancer

Docetaxel Consolidation Therapy Following Cisplatin, Vinorelbine, and Concurrent Thoracic... This regimen produced promising overall survival in patients with stage III NSCLC, but the vast majority of patients could not continue with the docetaxel consolidation because of toxicity. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Docetaxel Consolidation Therapy Following Cisplatin, Vinorelbine, and Concurrent Thoracic Radiotherapy in Patients with Unresectable Stage III Non-small Cell Lung Cancer

Tamura, Tomohide
Journal of Thoracic Oncology , Volume 1 (8) – Oct 1, 2006
Download PDF
6 pages

Loading next page...
 
/lp/wolters-kluwer-health/docetaxel-consolidation-therapy-following-cisplatin-vinorelbine-and-iTiOX9a5ye

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1556-0864

Abstract

This regimen produced promising overall survival in patients with stage III NSCLC, but the vast majority of patients could not continue with the docetaxel consolidation because of toxicity.

Journal

Journal of Thoracic Oncology – Wolters Kluwer Health

Published: Oct 1, 2006

There are no references for this article.